PharmGen Science, Inc.

004720.KS·KSE·Healthcare

FollowCompareShare

2,785.00+5.00 (+0.18%)today

At close: Oct 22, 3:30 PM KST · May be delayed up to 20 min · KRW

1D5D1M6MYTD1Y5Y10Y20YAll

MountainLineCandles

Indicators

Prices may be delayed up to 20 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close2,780.00

Open2,730.00

Day range2,690.002,805.00

52-week range2,590.004,485.00

Off day high−0.71%

Off 52-week high−37.90%

Volume13.12K

Avg. volume (3M)19.97K

Market cap62.98B

EPS (TTM)—

Forward P/E—

P/E ratio (TTM)—

Dividend yield—

Beta (5Y)0.38

Shares outstanding22.61M

Short interest—

Earnings date—

Analyst target—

Profit margin0.07%

Related companies

Compare ›

Moves togetherAlso watched

The stocks whose daily moves over the past year went most closely with 004720.KS's: the correlation of their daily returns, where 1 would be moving as one.

Company	Mkt cap	Price	Today
0093Sam-A Pharm. Co., Ltd009300.KQ · Correlation 0.45	83.55B	13,690.00	+0.29%
0248HLB innoVation Co.,Ltd.024850.KQ · Correlation 0.40	504.14B	15,880.00	−5.42%
0100Krc010040.KS · Correlation 0.33	65.21B	1,588.00	−2.04%
3505IGIS RESIDENCE REIT350520.KS · Correlation 0.31	115.76B	3,140.00	−0.95%
1061High Tech Pharm Co., Ltd.106190.KQ · Correlation 0.30	98.03B	9,220.00	−1.50%

What visitors to 004720.KS's page also look at.

Company	Mkt cap	Price	Today
3505IGIS RESIDENCE REIT350520.KS	115.76B	3,140.00	−0.95%
1061HTP106190.KQ	98.03B	9,220.00	−1.50%
0093Sam-A Pharm.009300.KQ	83.55B	13,690.00	+0.29%
0100Krc010040.KS	65.21B	1,588.00	−2.04%
0248HLB innoVation024850.KQ	504.14B	15,880.00	−5.42%

From the 4Search instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 20 min.

Latest news

All 004720.KS news ›

The Asia Business Daily·15h agoPositive

PharmGen Science Wins Approval for Pediatric Pranlukast Generic, Targets KRW 14 Billion Market

Published 22 Oct.2026 09:55(KST) PharmGen Science has secured the first generic version of pranlukast dry syrup for pediatric use and is preparing to enter the market. PharmGen Science said on October 22 that it had received marketing…

From articles in the 4Search news index.

In the news

1mentions in 30 days

1with it in the headline

Positivesentiment

Mentioned with

Avance Clinical Pty Ltd1Democratic Party of Korea1Korea Health Industry Development Institute1Mark Cuban Cost Plus Drug Company1Ministry of Food and Drug Safety1Novo Nordisk1Peptron1Propanc Biopharma, Inc.1

People in the coverage

Alan Bowe1Ashley Margol1Becker1Begzelma1Biostock1Cassie K.1

Themes

Anda1Bio Health1Economic1FDA1Issue1Korea1Kst1Newspaper1

Most coverage from

1. asiae.co.kr1

Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 1 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Search index. Terms of use.